MannKind Corp (NASDAQ:MNKD)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Recs

0
Player Avatar Treborn822 (91.85) Submitted: 8/17/2013 12:48:53 AM : Outperform Start Price: $6.12 MNKD Score: -19.86

Inhalable

Featured Broker Partners


Advertisement